_id
69148bc5ccc777a4e85d99ca
Ticker
PEPG
Name
PepGen Ltd
Exchange
NASDAQ
Address
321 Harrison Avenue, Boston, MA, United States, 02118
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://pepgen.com
Description
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.
Last Close
5.85
Volume
1604581
Current Price
5.815
Change
-0.5982905982905856
Last Updated
2025-12-03T11:58:28.546Z
Image
data:image/webp;base64,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
Ipo Date
2022-05-06T00:00:00.000Z
Market Cap
350615936
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8915
Sentiment Sources
2
Rating
4.2
Target Price
10
Strong Buy
3
Buy
1
Hold
0
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
339000
Gross Profit
-339000
Operating Expenses
18315000
Operating Income
-18654000
Interest Expense
-
Pretax Income
-18026000
Net Income
-18026000
Eps
-0.5504349706549699
Dividends Per Share
-
Shares Outstanding
68748224
Income Tax Expense
-
EBITDA
-17687000
Operating Margin
-
Total Other Income Expense Net
628000
Cash
142775000
Short Term Investments
20890000
Receivables
-
Inventories
-
Total Current Assets
166206000
Property Plant Equipment
21931000
Total Assets
190057000
Payables
766000
Short Term Debt
3163000
Long Term Debt
-
Total Liabilities
26917000
Equity
163140000
Depreciation
339000
Change In Working Capital
-4595000
Cash From Operations
-19259000
Capital Expenditures
97000
Cash From Investing
18903000
Cash From Financing
108052000
Net Change In Cash
107703000
PE
-
PB
1.167300334007601
ROE
-11.049405418658822
ROA
-9.484523064133391
FCF
-19356000
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
3
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
339000
Quarters > 0 > income Statement > gross Profit
-339000
Quarters > 0 > income Statement > operating Expenses
18315000
Quarters > 0 > income Statement > operating Income
-18654000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-18026000
Quarters > 0 > income Statement > net Income
-18026000
Quarters > 0 > income Statement > eps
-0.5504349706549699
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
32748646
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-17687000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
628000
Quarters > 0 > balance Sheet > cash
142775000
Quarters > 0 > balance Sheet > short Term Investments
20890000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
166206000
Quarters > 0 > balance Sheet > property Plant Equipment
21931000
Quarters > 0 > balance Sheet > total Assets
190057000
Quarters > 0 > balance Sheet > payables
766000
Quarters > 0 > balance Sheet > short Term Debt
3163000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
26917000
Quarters > 0 > balance Sheet > equity
163140000
Quarters > 0 > cash Flow > net Income
-18026000
Quarters > 0 > cash Flow > depreciation
339000
Quarters > 0 > cash Flow > change In Working Capital
-4595000
Quarters > 0 > cash Flow > cash From Operations
-19259000
Quarters > 0 > cash Flow > capital Expenditures
97000
Quarters > 0 > cash Flow > cash From Investing
18903000
Quarters > 0 > cash Flow > cash From Financing
108052000
Quarters > 0 > cash Flow > net Change In Cash
107703000
Quarters > 0 > ratios > PE
-0.5504349706549699
Quarters > 0 > ratios > PB
1.167300334007601
Quarters > 0 > ratios > ROE
-11.049405418658822
Quarters > 0 > ratios > ROA
-9.484523064133391
Quarters > 0 > ratios > FCF
-19356000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
334000
Quarters > 1 > income Statement > gross Profit
-334000
Quarters > 1 > income Statement > operating Expenses
23932000
Quarters > 1 > income Statement > operating Income
-23932000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-23087000
Quarters > 1 > income Statement > net Income
-23087000
Quarters > 1 > income Statement > eps
-0.7049757110568785
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
32748646
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-22661000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
845000
Quarters > 1 > balance Sheet > cash
35072000
Quarters > 1 > balance Sheet > short Term Investments
39581000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
77486000
Quarters > 1 > balance Sheet > property Plant Equipment
22782000
Quarters > 1 > balance Sheet > total Assets
102242000
Quarters > 1 > balance Sheet > payables
856000
Quarters > 1 > balance Sheet > short Term Debt
3140000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
31084000
Quarters > 1 > balance Sheet > equity
71158000
Quarters > 1 > cash Flow > net Income
-23087000
Quarters > 1 > cash Flow > depreciation
1271000
Quarters > 1 > cash Flow > change In Working Capital
-4384000
Quarters > 1 > cash Flow > cash From Operations
-23601000
Quarters > 1 > cash Flow > capital Expenditures
43000
Quarters > 1 > cash Flow > cash From Investing
14957000
Quarters > 1 > cash Flow > cash From Financing
98000
Quarters > 1 > cash Flow > net Change In Cash
-8561000
Quarters > 1 > ratios > PE
-0.7049757110568785
Quarters > 1 > ratios > PB
2.6762047343938846
Quarters > 1 > ratios > ROE
-32.44470052559094
Quarters > 1 > ratios > ROA
-22.580739813383932
Quarters > 1 > ratios > FCF
-23644000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
388000
Quarters > 2 > income Statement > gross Profit
-388000
Quarters > 2 > income Statement > operating Expenses
31321000
Quarters > 2 > income Statement > operating Income
-31321000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-30202000
Quarters > 2 > income Statement > net Income
-30202000
Quarters > 2 > income Statement > eps
-0.9243231464569551
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
32674720
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-29996000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1119000
Quarters > 2 > balance Sheet > cash
43633000
Quarters > 2 > balance Sheet > short Term Investments
54148000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
101047000
Quarters > 2 > balance Sheet > property Plant Equipment
24372000
Quarters > 2 > balance Sheet > total Assets
127393000
Quarters > 2 > balance Sheet > payables
2699000
Quarters > 2 > balance Sheet > short Term Debt
3117000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
35588000
Quarters > 2 > balance Sheet > equity
91805000
Quarters > 2 > cash Flow > net Income
-30202000
Quarters > 2 > cash Flow > depreciation
1325000
Quarters > 2 > cash Flow > change In Working Capital
3200000
Quarters > 2 > cash Flow > cash From Operations
-22930000
Quarters > 2 > cash Flow > capital Expenditures
125000
Quarters > 2 > cash Flow > cash From Investing
17149000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-5788000
Quarters > 2 > ratios > PE
-0.9243231464569551
Quarters > 2 > ratios > PB
2.0696421414955615
Quarters > 2 > ratios > ROE
-32.89799030553892
Quarters > 2 > ratios > ROA
-23.707739043746518
Quarters > 2 > ratios > FCF
-23055000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1492000
Quarters > 3 > income Statement > cost Of Revenue
380000
Quarters > 3 > income Statement > gross Profit
-380000
Quarters > 3 > income Statement > operating Expenses
23965000
Quarters > 3 > income Statement > operating Income
-24345000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-22859000
Quarters > 3 > income Statement > net Income
-22242000
Quarters > 3 > income Statement > eps
-0.6822075564194575
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
32602981
Quarters > 3 > income Statement > income Tax Expense
-617000
Quarters > 3 > income Statement > EBITDA
-22479000
Quarters > 3 > income Statement > operating Margin
-1631.7024128686328
Quarters > 3 > income Statement > total Other Income Expense Net
1486000
Quarters > 3 > balance Sheet > cash
49421000
Quarters > 3 > balance Sheet > short Term Investments
70770000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
123761000
Quarters > 3 > balance Sheet > property Plant Equipment
25148000
Quarters > 3 > balance Sheet > total Assets
150883000
Quarters > 3 > balance Sheet > payables
1752000
Quarters > 3 > balance Sheet > short Term Debt
3094000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
32263000
Quarters > 3 > balance Sheet > equity
118620000
Quarters > 3 > cash Flow > net Income
-22242000
Quarters > 3 > cash Flow > depreciation
380000
Quarters > 3 > cash Flow > change In Working Capital
-927000
Quarters > 3 > cash Flow > cash From Operations
-19475000
Quarters > 3 > cash Flow > capital Expenditures
228000
Quarters > 3 > cash Flow > cash From Investing
26501000
Quarters > 3 > cash Flow > cash From Financing
128000
Quarters > 3 > cash Flow > net Change In Cash
7132000
Quarters > 3 > ratios > PE
-0.6822075564194575
Quarters > 3 > ratios > PB
1.5982661820519306
Quarters > 3 > ratios > ROE
-18.750632271117855
Quarters > 3 > ratios > ROA
-14.741223331985712
Quarters > 3 > ratios > FCF
-19703000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-13.205764075067025
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1505000
Annuals > 0 > income Statement > gross Profit
-1505000
Annuals > 0 > income Statement > operating Expenses
96234000
Annuals > 0 > income Statement > operating Income
-97739000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-90598000
Annuals > 0 > income Statement > net Income
-89981000
Annuals > 0 > income Statement > eps
-2.8490261223155833
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
31583073
Annuals > 0 > income Statement > income Tax Expense
-617000
Annuals > 0 > income Statement > EBITDA
-89093000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
7141000
Annuals > 0 > balance Sheet > cash
49421000
Annuals > 0 > balance Sheet > short Term Investments
70770000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
123761000
Annuals > 0 > balance Sheet > property Plant Equipment
25148000
Annuals > 0 > balance Sheet > total Assets
150883000
Annuals > 0 > balance Sheet > payables
1752000
Annuals > 0 > balance Sheet > short Term Debt
3094000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
32263000
Annuals > 0 > balance Sheet > equity
118620000
Annuals > 0 > cash Flow > net Income
-89981000
Annuals > 0 > cash Flow > depreciation
5253000
Annuals > 0 > cash Flow > change In Working Capital
-5246000
Annuals > 0 > cash Flow > cash From Operations
-82372000
Annuals > 0 > cash Flow > capital Expenditures
497000
Annuals > 0 > cash Flow > cash From Investing
-37668000
Annuals > 0 > cash Flow > cash From Financing
88749000
Annuals > 0 > cash Flow > net Change In Cash
-31353000
Annuals > 0 > ratios > PE
-2.8490261223155833
Annuals > 0 > ratios > PB
1.357896411229135
Annuals > 0 > ratios > ROE
-75.8565166076547
Annuals > 0 > ratios > ROA
-59.63627446432004
Annuals > 0 > ratios > FCF
-82869000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1184000
Annuals > 1 > income Statement > gross Profit
-1184000
Annuals > 1 > income Statement > operating Expenses
83582000
Annuals > 1 > income Statement > operating Income
-84766000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-78553000
Annuals > 1 > income Statement > net Income
-78626000
Annuals > 1 > income Statement > eps
-3.3041687678601446
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
23796000
Annuals > 1 > income Statement > income Tax Expense
73000
Annuals > 1 > income Statement > EBITDA
-83582000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
6213000
Annuals > 1 > balance Sheet > cash
80774000
Annuals > 1 > balance Sheet > short Term Investments
29633000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
112678000
Annuals > 1 > balance Sheet > property Plant Equipment
28384000
Annuals > 1 > balance Sheet > total Assets
143052000
Annuals > 1 > balance Sheet > payables
1005000
Annuals > 1 > balance Sheet > short Term Debt
3004000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
34631000
Annuals > 1 > balance Sheet > equity
108421000
Annuals > 1 > cash Flow > net Income
-78626000
Annuals > 1 > cash Flow > depreciation
850000
Annuals > 1 > cash Flow > change In Working Capital
1951000
Annuals > 1 > cash Flow > cash From Operations
-68997000
Annuals > 1 > cash Flow > capital Expenditures
2599000
Annuals > 1 > cash Flow > cash From Investing
-32003000
Annuals > 1 > cash Flow > cash From Financing
-189000
Annuals > 1 > cash Flow > net Change In Cash
-100903000
Annuals > 1 > ratios > PE
-3.3041687678601446
Annuals > 1 > ratios > PB
1.119336659872165
Annuals > 1 > ratios > ROE
-72.51916141706864
Annuals > 1 > ratios > ROA
-54.963230154069855
Annuals > 1 > ratios > FCF
-71596000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
493000
Annuals > 2 > income Statement > gross Profit
-493000
Annuals > 2 > income Statement > operating Expenses
68301000
Annuals > 2 > income Statement > operating Income
-68301000
Annuals > 2 > income Statement > interest Expense
3396000
Annuals > 2 > income Statement > pretax Income
-65398000
Annuals > 2 > income Statement > net Income
-69104000
Annuals > 2 > income Statement > eps
-4.418491165575258
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
15639728
Annuals > 2 > income Statement > income Tax Expense
3706000
Annuals > 2 > income Statement > EBITDA
-67808000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2903000
Annuals > 2 > balance Sheet > cash
181752000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
58000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
186083000
Annuals > 2 > balance Sheet > property Plant Equipment
29884000
Annuals > 2 > balance Sheet > total Assets
217440000
Annuals > 2 > balance Sheet > payables
1362000
Annuals > 2 > balance Sheet > short Term Debt
5553000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
37809000
Annuals > 2 > balance Sheet > equity
179631000
Annuals > 2 > cash Flow > net Income
-69104000
Annuals > 2 > cash Flow > depreciation
493000
Annuals > 2 > cash Flow > change In Working Capital
4507000
Annuals > 2 > cash Flow > cash From Operations
-59265000
Annuals > 2 > cash Flow > capital Expenditures
3755000
Annuals > 2 > cash Flow > cash From Investing
-3755000
Annuals > 2 > cash Flow > cash From Financing
112193000
Annuals > 2 > cash Flow > net Change In Cash
48857000
Annuals > 2 > ratios > PE
-4.418491165575258
Annuals > 2 > ratios > PB
0.4440359002622042
Annuals > 2 > ratios > ROE
-38.46997455895697
Annuals > 2 > ratios > ROA
-31.78072111846946
Annuals > 2 > ratios > FCF
-63020000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
178000
Annuals > 3 > income Statement > gross Profit
-178000
Annuals > 3 > income Statement > operating Expenses
27109000
Annuals > 3 > income Statement > operating Income
-27109000
Annuals > 3 > income Statement > interest Expense
172000
Annuals > 3 > income Statement > pretax Income
-27281000
Annuals > 3 > income Statement > net Income
-27281000
Annuals > 3 > income Statement > eps
-1.218283967921544
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
22392973
Annuals > 3 > income Statement > income Tax Expense
-58558
Annuals > 3 > income Statement > EBITDA
-26931000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-172000
Annuals > 3 > balance Sheet > cash
132895000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4744000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
139986000
Annuals > 3 > balance Sheet > property Plant Equipment
636000
Annuals > 3 > balance Sheet > total Assets
143641000
Annuals > 3 > balance Sheet > payables
3240000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10547000
Annuals > 3 > balance Sheet > equity
133094000
Annuals > 3 > cash Flow > net Income
-27281000
Annuals > 3 > cash Flow > depreciation
178000
Annuals > 3 > cash Flow > change In Working Capital
2774000
Annuals > 3 > cash Flow > cash From Operations
-22599000
Annuals > 3 > cash Flow > capital Expenditures
500000
Annuals > 3 > cash Flow > cash From Investing
-500000
Annuals > 3 > cash Flow > cash From Financing
147656000
Annuals > 3 > cash Flow > net Change In Cash
124590000
Annuals > 3 > ratios > PE
-1.218283967921544
Annuals > 3 > ratios > PB
0.8580714555126452
Annuals > 3 > ratios > ROE
-20.497543089846275
Annuals > 3 > ratios > ROA
-18.992488217152484
Annuals > 3 > ratios > FCF
-23099000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.5504349706549699
Valuation > metrics > PB
1.167300334007601
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-11.049405418658822
Profitability > metrics > ROA
-10.845577175312563
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.16499325732499692
Risk > metrics > Interest Coverage
-55.02654867256637
Risk > final Score
-160
Risk > verdict
High
Liquidity > metrics > Current Ratio
42.30236701450751
Liquidity > metrics > Quick Ratio
42.30236701450751
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-165
Prev Risks > 1
-548
Prev Risks > 2
-196
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T00:54:15.163Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.52
Earnings History > 0 > eps Estimate
-0.6283
Earnings History > 0 > eps Difference
0.1083
Earnings History > 0 > surprise Percent
17.237
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.7
Earnings History > 1 > eps Estimate
-0.81
Earnings History > 1 > eps Difference
0.11
Earnings History > 1 > surprise Percent
13.5802
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.92
Earnings History > 2 > eps Estimate
-0.72
Earnings History > 2 > eps Difference
-0.2
Earnings History > 2 > surprise Percent
-27.7778
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.68
Earnings History > 3 > eps Estimate
-0.81
Earnings History > 3 > eps Difference
0.13
Earnings History > 3 > surprise Percent
16.0494
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-08
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.66
Earnings History > 4 > eps Estimate
-0.87
Earnings History > 4 > eps Difference
0.21
Earnings History > 4 > surprise Percent
24.1379
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.87
Earnings History > 5 > eps Estimate
-0.72
Earnings History > 5 > eps Difference
-0.15
Earnings History > 5 > surprise Percent
-20.8333
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.63
Earnings History > 6 > eps Estimate
-0.74
Earnings History > 6 > eps Difference
0.11
Earnings History > 6 > surprise Percent
14.8649
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-06
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.81
Earnings History > 7 > eps Estimate
-1.01
Earnings History > 7 > eps Difference
0.2
Earnings History > 7 > surprise Percent
19.802
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.98
Earnings History > 8 > eps Estimate
-0.88
Earnings History > 8 > eps Difference
-0.1
Earnings History > 8 > surprise Percent
-11.3636
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.82
Earnings History > 9 > eps Estimate
-0.81
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-1.2346
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.69
Earnings History > 10 > eps Estimate
-0.79
Earnings History > 10 > eps Difference
0.1
Earnings History > 10 > surprise Percent
12.6582
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.24
Earnings History > 11 > eps Estimate
-0.87
Earnings History > 11 > eps Difference
0.63
Earnings History > 11 > surprise Percent
72.4138
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.79
Earnings History > 12 > eps Estimate
-1
Earnings History > 12 > eps Difference
0.21
Earnings History > 12 > surprise Percent
21
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.23
Earnings History > 13 > eps Estimate
-0.76
Earnings History > 13 > eps Difference
-0.47
Earnings History > 13 > surprise Percent
-61.8421
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-06-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-18.94
Earnings History > 14 > eps Estimate
-4.61
Earnings History > 14 > eps Difference
-14.33
Earnings History > 14 > surprise Percent
-310.846
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-11
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.36
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.36
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-10-01
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.54
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.54
Earnings History > 16 > surprise Percent
-
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow Much Upside is Left in PepGen (PEPG)? Wall Street Analysts Think 75.44% WV News
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$10
Analyst Picks
Strong Buy
3
Buy
1
Hold
0
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 73.31% of the total shares of PepGen Ltd
1.
RA Capital Management, LLC(32.5904%)
since
2025/06/30
2.
Point72 Asset Management, L.P.(8.4122%)
since
2025/06/30
3.
Millennium Management LLC(4.6013%)
since
2025/06/30
4.
Viking Global Investors LP(4.5197%)
since
2025/06/30
5.
Adage Capital Partners Gp LLC(4.1159%)
since
2025/06/30
6.
Vanguard Group Inc(2.8568%)
since
2025/06/30
7.
LAURION CAPITAL MANAGEMENT LP(2.4719%)
since
2025/06/30
8.
Woodline Partners LP(2.1083%)
since
2025/06/30
9.
BlackRock Inc(1.9757%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(1.4402%)
since
2025/07/31
11.
Suvretta Capital Management, LLC(0.9146%)
since
2025/06/30
12.
Prosight Management, LP(0.7438%)
since
2025/06/30
13.
Opaleye Management Inc(0.7317%)
since
2025/06/30
14.
Geode Capital Management, LLC(0.6131%)
since
2025/06/30
15.
Vanguard Institutional Extnd Mkt Idx Tr(0.6063%)
since
2025/07/31
16.
iShares Biotechnology ETF(0.5223%)
since
2025/08/31
17.
Sphera Funds Management Ltd.(0.477%)
since
2025/06/30
18.
Ikarian Capital, LLC(0.4573%)
since
2025/06/30
19.
Vanguard Balanced Index Inv(0.4516%)
since
2025/07/31
20.
RBF LLC(0.3049%)
since
2025/06/30
21.
Fidelity Extended Market Index(0.2818%)
since
2025/07/31
22.
Bridgeway Capital Management, LLC(0.2803%)
since
2025/06/30
23.
Bridgeway Ultra-Small Company Market(0.2406%)
since
2025/06/30
24.
Qube Research & Technologies(0.2226%)
since
2025/06/30
25.
Goldman Sachs Group Inc(0.2153%)
since
2025/06/30
26.
State Street Corp(0.2108%)
since
2025/06/30
27.
Zacks Small-Cap Core Inv(0.116%)
since
2025/05/31
28.
iShares Micro-Cap ETF(0.1144%)
since
2025/08/31
29.
Extended Equity Market Fund K(0.1142%)
since
2025/06/30
30.
Fidelity Total Market Index(0.0935%)
since
2025/07/31
31.
Fidelity Series Total Market Index(0.0763%)
since
2025/07/31
32.
Fidelity Nasdaq Composite Index(0.0691%)
since
2025/07/31
33.
NT Ext Equity Mkt Idx Fd - L(0.0619%)
since
2025/06/30
34.
Northern Trust Extended Eq Market Idx(0.0619%)
since
2025/06/30
35.
Spartan Extended Market Index Pool F(0.0575%)
since
2025/07/31
36.
iShares Nasdaq US Biotech ETF USD Acc(0.0525%)
since
2025/08/31
37.
Spartan Total Market Index Pool G(0.0341%)
since
2025/07/31
38.
Vanguard Instl Ttl Stk Mkt Idx InstlPls(0.0304%)
since
2025/07/31
39.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0304%)
since
2024/12/31
40.
NT Ext Equity Mkt Idx Fd - NL(0.0301%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.52
EPS Estimate
-0.6283
EPS Difference
0.1083
Surprise Percent
17.237%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.